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The leucine-rich repeat-containing G-protein-
coupled receptors (Lgrs) are a large membrane
protein family mediating signaling events during
development and in the adult organism. Type 2
Lgrs, including Lgr4, Lgr5, and Lgr6, play crucial
roles in embryonic development and in several can-
cers. They also regulate adult stem cell mainte-
nance via direct association with proteins in the
Wnt signaling pathways, including Lrp5/6 and friz-
zled receptors. The R-spondins (Rspo) were recently
identified as functional ligands for type 2 Lgrs and
were shown to synergize with both canonical and
noncanonical Wnt signaling pathways. We deter-
mined and report the structure of the Lgr4 ectodo-
main alone and bound to Rspo1. The structures
reveal an extended horseshoe leucine-rich repeat
(LRR) receptor architecture that binds, with its
concave side, the ligand furin-like repeats via an
intimate interface. The molecular details of ligand/
receptor recognition provide insight into receptor
activation and could serve as template for stem-
cell-based regenerative therapeutics development.
INTRODUCTION
The Wnt proteins are a family of evolutionarily highly conserved
secreted signaling molecules that play crucial roles in many
developmental stages, in the self-renewal and maintenance of
adult stem cells, and in several diseases, including cancer
(Clevers and Nusse, 2012; Holland et al., 2013; MacDonald
et al., 2009). Three Wnt downstream signaling pathways have
been characterized, including one canonical Wnt LRP5/6 b-cat-
enin pathway and two noncanonical pathways: Wnt planar cell
polarity (PCP) andWnt/calcium. The canonicalWnt pathway reg-
ulates gene transcription, the noncanonical Wnt/PCP pathway
regulates the cytoskeleton responsible for the shape of the
cell, and the noncanonical Wnt/calcium pathway regulates
calcium levels inside the cell. All three Wnt signaling pathways
are initiated by Wnt-Frizzled receptor attachment followed by a
sequential signal relay through coreceptors and/or downstream
protein effectors. The molecular mechanisms that regulate the
Wnt signaling pathways are still poorly understood (MacDonald
et al., 2009; Nusse and Varmus, 2012).Structure 21, 1683–16The R-spondins (Rspos) are members of the thrombospondin
type 1 repeat (TSR1)-containing protein superfamily (Kamata
et al., 2004). Rspos are capable of synergizing with both canon-
ical and noncanonical PCP/Wnt pathways (Kazanskaya et al.,
2004; Kim et al., 2006; Nam et al., 2006; Ohkawara et al.,
2011), suggesting that they are essential during Wnt-dependent
developmental stages and stem cell growth (Blaydon et al.,
2006; Jin and Yoon, 2012; Kim et al., 2008; Tomaselli et al.,
2008). The four Rspomembers share the same domain architec-
ture, containing two N-terminal furin-like (FU) repeats, a TSR1
domain, and a positively charged C-terminal region of various
lengths. The frequent occurrence of conserved FU repeats in
numerous important growth factors and receptors implies func-
tional significance (Li et al., 2009). The positively charged TSR1
domain and C terminus of Rspos have been predicted to
bind glycosaminoglycan (GAG)/proteoglycan and heparin (Nam
et al., 2006). Despite their similarity, the four known Rspos serve
in different developmental events: Rspo1 regulates sex develop-
ment; Rspo2 regulates development of limbs, lungs, and hair
follicles; Rspo3 regulates placenta development; and Rspo4
regulates nail development (de Lau et al., 2012).
The leucine-rich, repeat-containing G-protein-coupled recep-
tors (Lgr) are a distinct group of highly conserved proteins. They
contain a large ectodomain with multiple leucine-rich repeats
(LRRs) involved in ligand binding that are connected via a
cysteine-rich hinge region to a seven-transmembrane domain
responsible for heterotrimeric G-protein activation. Phylogeneti-
cally, the Lgr family proteins are categorized into threemain types
(Bella et al., 2008; Hsu et al., 2000; Kajava, 1998). Type 1 includes
threehormone receptors, Lgr1, Lgr2, andLgr3, also knownas fol-
licle-stimulating hormone receptor (FSHR), luteinizing hormone
receptor, and thyroid-stimulating hormone receptor, respec-
tively. Type 3 includes the relaxin hormone receptors Lgr7 and
Lgr8 (Kong et al., 2010). The type 2 receptor family, including
Lgr4, Lgr5, and Lgr6, is characterized by the presence of an ex-
tra-large LRR region (16–18 LRRs) within the ectodomain. Type
2 receptors are known to play crucial roles in the embryonic
development and are involved in several types of cancer (Barker
and Clevers, 2010). They have also drawn significant attention
recently because of their roles in adult stem cells, especially after
Lgr5 and Lgr6 were identified as specific stem cells marker in
multiple adult tissues (Barker et al., 2007; Jaks et al., 2008; Snip-
pert et al., 2010). Rspos were recently identified as the functional
ligands of this receptor class (Carmon et al., 2011; de Lau et al.,
2011; Glinka et al., 2011; Ruffner et al., 2012), documenting their
capability to potentiateWnt signaling through the three type 2 Lgr
proteins. Lgrs4/5/6 were also found to physically associate with89, September 3, 2013 ª2013 Elsevier Ltd All rights reserved 1683
Table 1. Data Collection and Refinement Statistics
Lgr4 Lgr4 Complex
Native (NH4)2PtCl4 (SAD) Lgr4/Rspo1
Resolution range (A˚) 113.8-2.66 (2.8-2.66) 49.53-2.92 (3.08-2.92) 50 - 3.2 (3.31-3.2)
Space group C 2 2 21 P 4 21 2 C 2 2 21
Unit cell 60.29 158.582 227.609 90 90 90 152.615 152.615 111.458 90 90 90 103.379 160.923 82.216 90 90 90
Total reflections 202,138 384,476 51,022
Unique reflections 31,899 35,527 11,576
Multiplicity 6.3 (6.4) 13.1 (13.7) 4.4 (4.4)
Completeness (%) 99.76 (99.87) 99.31 (99.28) 98.34 (96.29)
Mean I/sigma(I) 12.57 (1.77) 16.32 (1.83) 10.00 (1.43)
Wilson B-factor 64.49 75.15 94.06
Rmerge 0.088 (0.872) 0.096 (1.364) 0.087 (0.966)
Rwork 0.2375 (0.3584) 0.2560 (0.3981)
Rfree 0.2732 (0.4375) 0.2938 (0.4582)
Number of atoms 6,807 4,041
Macromolecules 6,601 4,027
Ligands 28 14
Water 178 0
Protein residues 851 526
Root mean square (bonds) 0.005 0.003
Root mean square (angles) 1.18 1.00
Ramachandran favored (%) 97 92
Ramachandran outliers (%) 0 0
Clashscore 14.14 13.15
Average B-factor 66.60 70.60
Macromolecules 66.80 70.50
Ligands 75.80 93.40
Solvent 58.90
Statistics for the highest-resolution shell are shown in parentheses.
Structure
Structures of Lgr4 and the Lgr4/R-Spondin1 ComplexLrp5/6 and frizzled receptors, further highlighting their critical role
in Wnt signaling (Binnerts et al., 2007; Carmon et al., 2012; Nam
et al., 2006; Schuijers and Clevers, 2012; Wei et al., 2007).
Understanding the structural basis of ligand-receptor binding
and ligand-induced receptor/coreceptor activation is vital to un-
derstanding the mechanism of signal transduction. We therefore
determined and report here the crystal structures of unliganded
Lgr4 and the Lgr4/Rspo1 complex. The structures reveal an
extended horseshoe LRR receptor architecture that binds, with
its concave side, the ligand furin-like repeats via an intimate inter-
face. Themolecular details of ligand/receptor recognitionprovide
insight into receptor activation and could serve as template for
future stem-cell-based regenerative therapeutics development.
RESULTS AND DISCUSSION
The Xenopus Lgr4 ectodomain (residues 24–455) and full-length
human Rspo1 were expressed in human embryonic kidney 293T
cells (HEK 293T cells) and crystallized. For an alignment between
human and Xenopus Lgr4, see Figure S1 available online. The
C-terminal hinge region in the ectodomain of type-2 Lgr recep-
tors contains five cysteine residues and is predicted to be disor-
dered. The function of this region in the other two Lgr types is to1684 Structure 21, 1683–1689, September 3, 2013 ª2013 Elsevier Ltfacilitate G-protein-coupled receptor (GPCR) activation. Since
the Rspo-mediated Wnt signal doesn’t involve GPCR activation
(Ruffner et al., 2012) and the full ectodomain of Lgr4 protein
aggregates in solution, the hinge region was excluded from the
construct used for crystallographic analysis.
Structure of Lgr4
The unliganded Lgr4 ectodomain crystals diffracted to 2.6 A˚, and
a 2.9 A˚ single-wavelength anomalous diffraction (SAD) data set
from a platinum derivative was used for the initial phase calcu-
lation. The final model is refined to an Rfree of 27% at 2.6 A˚
resolution (Table 1).
The Lgr4 crystals contain two Lgr4 molecules in each asym-
metric unit (root-mean-square deviation [rmsd] between Ca
positions of 0.4 A˚). The Lgr4 structure reveals a large, horse-
shoe-shaped molecular architecture consisting of 16 LRRs that
adopt a right-handed solenoid (Figure 1A). The inner and the
outer radii of the Lgr4 horseshoe are 24 A˚ and 40 A˚, respec-
tively. Notably, unlike many other LRR-containing protein struc-
tures, the Lgr4 solenoid has a slight (20) right-handed twist.
The concave inner surface, formed by 16 parallel b strands
from the LRR region and two antiparallel strands from the N-ter-
minal cap region, assembles into a highly curved, continuousd All rights reserved
Figure 1. Structure of Unliganded Lgr4
(A) Two orthogonal views of the structure of the
unbound Lgr4 ectodomain colored in green. The
sugar moieties at the glycosylation sites are drawn
as gray spheres. The N and C termini, as well as
the individual LRR repeats, are labeled. LRRNT,
N-terminal LRR capping region.
(B) Two orthogonal views of the Lgr4 dimer (one
molecule is colored in green and the other in cyan)
observed in the crystals. The Lgr4 ectodomain is
dimeric in solution as judged by gel filtration and
dynamic light scattering.
See also Figure S1.
Structure
Structures of Lgr4 and the Lgr4/R-Spondin1 Complexb sheet that spans 180 of arc. The convex outer surface con-
tains more diverse secondary structure elements, including
loops of various lengths, a helices, and b strands. The Lgr4 sole-
noid is further stabilized by three disulfide bonds, two (C32-C38
and C36-C46) located in the N-terminal cap region and one
(C342-C367) located between LRR13 and LRR14. Interestingly,
one free cysteine residue (C223) is also present.
Among the 16 LRR modules, two (LRR11 and LRR12) do not
strictly obey the LxxLxLxxNxL rule (Kobe and Kajava, 2001).
Instead, the N residues are replaced by A309 and T332, respec-
tively. As a result, the asparagine ladder breaks in this region,
rendering two longer b strands.
Primary sequence analysis indicates that the Lingo-1 ectodo-
main is the closest homolog to Lgr4 among all reported LRR-
containing structures. Indeed, the N-terminal region of these
two structures can be superimposed with an rmsd between
equivalent Ca positions of 1.2 A˚ over a stretch of 155 residues
(Mosyak et al., 2006), while Lgr4 and FSHR/Lgr1 (Fan and Hen-
drickson, 2005; Jiang et al., 2012) can be superimposed with an
rmsd between equivalent Ca positions of 2.4 A˚. over 176 resi-Structure 21, 1683–1689, September 3, 2013 ªdues. The presence of the unique gradual
right-handed twist in the Lgr4 structure
(but not in Lingo-1 or FSHR) does not
seem to be essential for Rspo binding
(see below) but could be functionally
relevant for formation of higher-order
ligand/receptor/coreceptor assemblies,
possibly involving other proteins regu-
lating Wnt signaling.
N-linked glycosylation was observed in
all five predicted locations: N71, N202,
N297, N317, and N385. The first three
were not included in the model due to
their weak electron density. None of
these glycosylation sites are located at
the concave site, where they could inter-
fere with ligand binding.
Lgr4 forms a dimer in solution, as
judged by gel filtration chromatography
and dynamic light scattering (data not
shown), and the two Lgr4 copies in the
crystal AU bind each other in a tail-to-
tail assembly with the N-terminal regions,
including the LRRNT and the first fourLRRs, interacting side by side (Figure 1B). Several salt bridges
(including R159-D41 and D41-K111), hydrogen bonds, and van
der Waals contacts participate in this assembly, which is also
observed in other distinct Lgr4 crystal forms that we obtained
(not shown), suggesting functional relevance.
Overall Structure of the Lgr/Rspo Complex
Crystals of the complex diffracted to 3.2 A˚ and the structure was
determined by molecular replacement using the structure of
unbound Lgr4 (Table 1). As most other known LRR-containing
receptors, Lgr4 binds its Rspo ligand at the concave LRR surface
region (Figure 2A), somewhat closer to its N terminus. The Lgr4/
Rspo1 complex migrates as a 1:1 heterodimer in a gel filtration
column and the asymmetric unit of the crystals contains one
ligand and one receptor molecules.
Structure of Rspo1 in the Lgr4/Rspo1 Complex
The N-terminal receptor-binding domain of Rspo1, containing
the FU repeats, consists of 12 b strands (B1–B12) forming six
beta hairpins assembled irregularly side by side. Specifically,2013 Elsevier Ltd All rights reserved 1685
Figure 2. Structure of the Lgr4/Rspo Complex
(A) Two orthogonal views of the ligand/receptor complex. Lgr4 is colored in blue and R-spondin (Rspo) in magenta. The inserts are superimpositions of ligand-
bound (blue) and unliganded (green) Lgr4. Secondary structure elements in Rspo are labeled.
(B) The Lgr4/Rspo complex with either Lgr4 (left) or Rspo complex (right) are drawn as solvent-accessible surfaces and color-coded by electrostatic surface
potential. This panel illustrates the complementary-charged surfaces that constitute the Lgr4/Rspo interface.
See also Figure S2.
Structure
Structures of Lgr4 and the Lgr4/R-Spondin1 Complexeach of the two FU repeats consists of three hairpins, the folding
of which resembles interconnected paper clips. The beta hair-
pins are further stabilized by eight disulfide bonds (C40-C47,
C44-C53, C56-C75, C79-C94, C97-C105, C102-C111, C114-
C125, and C129-C142). The Rspo construct used for crystalliza-
tion also included the adjacent TSR1 and the C-terminal basic
residue cluster, but these regions were not well ordered in the
electron-density map and were not included in the model.
Lgr4/Rspo1 Complex Interface
The Lgr4/Rspo1 interface involves repeats LRR1 and LRR3–
LRR9 in Lgr4, which bind to residues in five of the six hairpins1686 Structure 21, 1683–1689, September 3, 2013 ª2013 Elsevier Ltin the two FU repeats. It buries approximately 1,860 A˚2 of surface
area, which is smaller, for example, than the FSHR/FSH interface
(2,600 A˚2) (Fan and Hendrickson, 2005). The interface (Figure 3)
is composed of mostly polar contacts that surround a hydro-
phobic patch in the middle. The polar interactions include
salt bridges (between K59Rspo1 and D165Lgr4, R87Rspo1 and
D140Lgr4, R87Rspo1 and D164Lgr4, K122 Rspo1 and E231Lgr4, and
D85Rspo1 and R138Lgr4) and several hydrogen bonds (including
between K59 Rspo1 and N117 Lgr4, T112 Rspo1 and H160 Lgr4,
and N109 Rspo1 and E255 Lgr4). The hydrophobic patch dis-
plays an interesting ‘‘clamping’’ binding mode. Specifically,
F74 of Rspo1 is clamped by four Lgr4 hydrophobic residuesd All rights reserved
Figure 3. The Lgr4/Rspo Interface
Two orthogonal views of the binding interface
between Lgr4 (blue) and Rspo (magenta). Inter-
acting residues are drawn as stick figures and
labeled. Secondary structure elements in Rspo are
also labeled. The inset in the right panel is a zoom-
in of the hydrophobic ‘‘clamp’’ region of the Lgr4/
Rspo interface, with the Rspo solvent-accessible
surface drawn in magenta.
Structure
Structures of Lgr4 and the Lgr4/R-Spondin1 Complex(H160, W162, V208, and H210) that fully surround it (Figure 3,
inset). This hydrophobic clamp is further enhanced by two
adjacent hydrophobic residues: F78 in Rspo1 and V207 in
Lgr4. These seven residues composing the hydrophobic patch
are strictly conserved in all four Rspo members and Lgr4, Lgr5,
and Lgr6 across species, indicating the importance of this
interaction.
Electrostatic Rspo1/Lgr4 Interactions
Lgr4 contains a highly charged patch in the ligand binding region.
The receptor binding region of Rspo1 is also highly charged (Fig-
ure 2B). The complementary-shaped surfaces and the comple-
mentary charges result in the formation of the highly intimate
interface, which includes many salt bridges. The structure thus
indicates that the stability of this interface is dependent on pH
and ion strength, suggesting that the binding might be regulated
by the environmental conditions during signaling, for example
pH change upon endocytosis. The adjacent TSR1 and C-termi-
nal regions in Lgr4 are highly positively charged, which could
facilitate interactions with negatively charged proteins and/or
GAG/proteoglycans.
Comparison of Ligand-Bound and Free Lgr4
Ligand binding does not induce significant conformational
changes in Lgr4. Indeed, the two structures can be superim-
posed with an rmsd between Ca positions of approximately
0.7 A˚ (Figure 2, insets). Interestingly, though, ligand binding
causes disruption of the Lgr4 dimers both in solution and in
the crystals. The biological significance of this is yet unclear.
In addition, crystal-packing interactions result in the formation
of 2:2 Lgr4/Rspo1 heterotetramers (Figure S2), which are very
similar in architecture to the 2:2 heterotetramers observed in
the Toll-like receptor TLR4-MD2 structure (Kim et al., 2007;
Ohto et al., 2012; Park et al., 2009). Specifically, two Lgr4
molecules bind each other side by side with the Lgr4 concave
regions facing opposite directions. Each Rspo1 molecule con-
tacts both Lgr4 molecules in the 2:2 complex; in addition to
the primary binding interface described above, the Rspo1 N
terminus interacts with the other Lgr4 molecule to stabilize the
2:2 complex, burying a total surface area of 4,248 A˚2 in the
process.Structure 21, 1683–1689, September 3, 2013 ªImplications for Receptor
Activation
The fact that ligand binding does not
significantly alter the conformation of
Lgr4 excludes the possibility of a simple
mechanical signal-relaying mechanism.
Instead, changes in the Lgr4 receptoroligomerization state and/or orientation on the cell surface
might be important for signal transduction. In the case of the
TLR4-MD2 complex, it was proposed that the 2:2 assembly
brings the C-terminal regions of two TLR ectodomains into
juxtaposition in order to facilitate signaling initiation inside the
cell mediated by their intracellular TIR domains (Kim et al.,
2007; Ohto et al., 2012; Park et al., 2009). However, Rspo/Lgr
binding does not activate the heterotetrameric G proteins and
an architecturally similar 2:2 Lgr4/Rspo1 complex could serve
a different purpose. A possible mechanism could be that
Rspo1 binding results in alterations in the architecture of the
Lgr4 receptor assemblies on the cell surface, which affect their
physical association with coreceptors, such as Lrp and Frizzled,
triggering the activation of the latter. Rspo1 binding could
also facilitate recruitment of other signaling components to
the Lgr4/Lrp/Frizzled complexes via interactions involving the
TSR1 or C-terminal domains.
Implications for Drug Design
The Lgr4-Rspo interactions can be an important drug target
because they regulate, via direct association withWnt receptors,
stem cell development and cancer progression. Our structures
suggest that the relatively small Lgr/Rspo binding interface can
be targeted by small molecule inhibitors to alter the downstream
signaling outcomes. Indeed, the clamp-type binding module can
bemimicked in organicmolecules using structure-based design.
Thus, the data reported here provide a template that could facil-
itate the development of novel stem-cell-based regenerative
therapeutics.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
A Xenopus Lgr4 (GeneID:100144922) construct (residue 24–455) and
full-length human Rspo1 (GeneID:284654) were cloned into a modified
pcDNA3.1+ vector (Invitrogen) and expressed in HEK 293T cells for crystalliza-
tion. The purification of the secreted recombinant proteins via Protein A affinity
chromatographywas facilitated by addition ofC-terminal Fc tags. The complex
was prepared by mixing Lgr4 and Rspo1 in 1:1.5 molar ratio and purified by
size-exclusion chromatography (GEBiosciences). The fractions were analyzed
in SDS-PAGE. Purified Lgr4 and Lgr4/Rspo1 complex were both concentrated
to 10 mg/ml in HBS buffer (20 mM HEPES [pH 7.2], 150 mM NaCl).2013 Elsevier Ltd All rights reserved 1687
Structure
Structures of Lgr4 and the Lgr4/R-Spondin1 ComplexCrystallization and Structure Determination
The initial crystallization conditions were identified using crystal screen Index
and PEG/ION kits (Hampton Research) using robot screening (TTP LabTech’s
Mosquito). After several rounds of optimization using hanging drop vapor
diffusion at room temperature, crystals of both Lgr4 alone and in complex
with Rspo1 grew to optimal size. The unliganded LRR ectodomain region
was crystallized against a reservoir containing 22% PEG3350, 200 mM
MgCl2, and 100mMBisTris (pH 5.7). The Lgr4/Rspo1 complex was crystallized
against a reservoir containing 17% PEG3350, 30 mM citric acid, and 100 mM
BisTris-propane (pH 7.6). Crystals were frozen in liquid nitrogen with 20%
glycerol as cryoprotectant. Diffraction data were collected at beamline
NE-CAT ID-24 of the Advanced Photon Source at Argonne National Labora-
tory. Data images were processed using HKL2000 (Otwinoski and Minor,
1997). A 2.9 A˚ SAD Lgr4 crystal data set from a platinum (NH4)2PtCl4 derivative
was used for the initial phase calculation in PHENIX. The initial phase map was
clear enough for Lgr4 model building in the program Coot (Emsley and Cow-
tan, 2004). The model was then refined using a higher-resolution data set.
The complex structure was determined by molecular replacement with the
program Phaser (McCoy et al., 2007) using the Lgr4 structure as a search
model. The map of the receptor binding region of Rspo1 was clear enough
for initial model building. The model was then built and refined iteratively using
Coot and PHENIX Refine in the program suite PHENIX (Adams et al., 2010).
The crystallographic analysis statistics are presented in Table 1.
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